[go: up one dir, main page]

NO970165D0 - Corticotropin release factor-binding protein inhibitors and their use - Google Patents

Corticotropin release factor-binding protein inhibitors and their use

Info

Publication number
NO970165D0
NO970165D0 NO970165A NO970165A NO970165D0 NO 970165 D0 NO970165 D0 NO 970165D0 NO 970165 A NO970165 A NO 970165A NO 970165 A NO970165 A NO 970165A NO 970165 D0 NO970165 D0 NO 970165D0
Authority
NO
Norway
Prior art keywords
binding protein
protein inhibitors
release factor
corticotropin release
corticotropin
Prior art date
Application number
NO970165A
Other languages
Norwegian (no)
Other versions
NO970165L (en
Inventor
Dominic P Behan
Phillip J Lowry
Jr Wylie Walker Vale
Stephen C Heinrichs
Steven W Sutton
Jean E F Rivier
Errol Desouza
Original Assignee
Neurocrine Biosciences Inc
Salk Inst
Univ Reading
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US1995/008867 external-priority patent/WO1996002569A1/en
Application filed by Neurocrine Biosciences Inc, Salk Inst, Univ Reading filed Critical Neurocrine Biosciences Inc
Publication of NO970165D0 publication Critical patent/NO970165D0/en
Publication of NO970165L publication Critical patent/NO970165L/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/57509Corticotropin releasing factor [CRF] (Urotensin)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO970165A 1994-07-15 1997-01-14 Corticotropin release factor-binding protein inhibitors and their use NO970165L (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US27624094A 1994-07-15 1994-07-15
US48477695A 1995-06-07 1995-06-07
PCT/US1995/008867 WO1996002569A1 (en) 1994-07-15 1995-07-14 Corticotropin-releasing factor-binding-protein inhibitors and their use

Publications (2)

Publication Number Publication Date
NO970165D0 true NO970165D0 (en) 1997-01-14
NO970165L NO970165L (en) 1997-03-14

Family

ID=26957870

Family Applications (1)

Application Number Title Priority Date Filing Date
NO970165A NO970165L (en) 1994-07-15 1997-01-14 Corticotropin release factor-binding protein inhibitors and their use

Country Status (7)

Country Link
EP (1) EP0771323A1 (en)
JP (2) JPH10503187A (en)
CN (1) CN1157620A (en)
AU (1) AU705984B2 (en)
CA (1) CA2195197A1 (en)
MX (1) MX9700413A (en)
NO (1) NO970165L (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107058237A (en) * 2016-12-07 2017-08-18 陈锋 Hybridoma cell strain and the anti-CRH antibody C D17 based on hybridoma cell strain and its application of context of detection
CN107043752A (en) * 2016-12-07 2017-08-15 陈锋 Hybridoma cell strain and the anti-CRH antibody N D19 based on hybridoma cell strain and its application of context of detection
KR20240023691A (en) * 2020-08-12 2024-02-22 스프루스 바이오사이언시스 인코포레이티드 Methods and compositions for treating polycystic ovary syndrome

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4908352A (en) * 1987-09-28 1990-03-13 The Salk Institute For Biological Studies Urotensin peptides
US5464757A (en) * 1991-01-15 1995-11-07 The Salk Institute For Biological Studies DNA encoding CRF binding protein

Also Published As

Publication number Publication date
NO970165L (en) 1997-03-14
AU3128395A (en) 1996-02-16
CN1157620A (en) 1997-08-20
JPH10503187A (en) 1998-03-24
EP0771323A1 (en) 1997-05-07
MX9700413A (en) 1998-05-31
CA2195197A1 (en) 1996-02-01
AU705984B2 (en) 1999-06-03
JP2001348400A (en) 2001-12-18

Similar Documents

Publication Publication Date Title
NO20001323D0 (en) Dipeptide-apoptosis inhibitors and their use
NO964958D0 (en) Aluminum-scandium alloys and their use
NO972983D0 (en) Sulfonamides and their use
IS4481A (en) Dihydropyramidine and their use
DK543189D0 (en) LYSYLOXIDASE INHIBITORS AND THEIR USE
NO990296D0 (en) The HPPD gene and inhibitors
NO20000700L (en) Interleukin-18 proteins and their preparation and use
DK1021410T3 (en) Prostaglandin agonists and their use in the treatment of bone conditions
NO983965D0 (en) Polymer-organolay composites and their preparation
NO942193D0 (en) Metallocenes and methods for their preparation and use
NO972125L (en) Hemorrhoid blends and methods of use
NO985340D0 (en) Microparticles and their use in wound care
DK0835266T3 (en) Modified / chimeric superantigens and their use
NO973338D0 (en) N- (4-aryl-thiazol-2-yl) -sulfonamide derivatives and their use
DK0804078T3 (en) Composition and use thereof
NO20003067L (en) Antipicornavirus compounds and methods for their use and preparation
NO995513D0 (en) N-triazolyl-2-indolecarboxamides and their use as CCK-A agonists
NO984836D0 (en) Substituted benzylamines and their use in the treatment of depression
NO963723D0 (en) Floating point reducing additives and their use
NO971505D0 (en) Trophine and trophine helper proteins
IS4312A (en) Squalene ligase inhibitors and their use
NO20013085D0 (en) Phosphorus-organic compounds and their use
NO970165D0 (en) Corticotropin release factor-binding protein inhibitors and their use
NO992310D0 (en) Inhibitors and their use in oils
NO984921D0 (en) Tienopyridine derivatives and their use

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application